BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 1649953)

  • 1. Labeling inhibin and identifying inhibin binding to cell surface receptors.
    Woodruff TK; Battaglia J; Borree J; Rice GC; Mather JP
    Methods Enzymol; 1991; 198():347-58. PubMed ID: 1649953
    [No Abstract]   [Full Text] [Related]  

  • 2. Stage-specific binding of inhibin and activin to subpopulations of rat germ cells.
    Woodruff TK; Borree J; Attie KM; Cox ET; Rice GC; Mather JP
    Endocrinology; 1992 Feb; 130(2):871-81. PubMed ID: 1310280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of an inhibin receptor in gonadal tumors from inhibin alpha-subunit knockout mice.
    Draper LB; Matzuk MM; Roberts VJ; Cox E; Weiss J; Mather JP; Woodruff TK
    J Biol Chem; 1998 Jan; 273(1):398-403. PubMed ID: 9417095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A surface component on GH3 pituitary cells that recognizes transforming growth factor-beta, activin, and inhibin.
    Cheifetz S; Ling N; Guillemin R; Massagué J
    J Biol Chem; 1988 Nov; 263(33):17225-8. PubMed ID: 2903159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of activin/inhibin receptor and binding protein genes and regulation of activin/inhibin peptide secretion in human adrenocortical cells.
    Vänttinen T; Kuulasmaa T; Liu J; Voutilainen R
    J Clin Endocrinol Metab; 2002 Sep; 87(9):4257-63. PubMed ID: 12213882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rodent adrenocortical cells display high affinity binding sites and proteins for inhibin A, and express components required for autocrine signalling by activins and bone morphogenetic proteins.
    Farnworth PG; Wang Y; Leembruggen P; Ooi GT; Harrison C; Robertson DM; Findlay JK
    J Endocrinol; 2006 Mar; 188(3):451-65. PubMed ID: 16522726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Betaglycan binds inhibin and can mediate functional antagonism of activin signalling.
    Lewis KA; Gray PC; Blount AL; MacConell LA; Wiater E; Bilezikjian LM; Vale W
    Nature; 2000 Mar; 404(6776):411-4. PubMed ID: 10746731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular cloning and binding properties of the human type II activin receptor.
    Donaldson CJ; Mathews LS; Vale WW
    Biochem Biophys Res Commun; 1992 Apr; 184(1):310-6. PubMed ID: 1314589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation of fluoresceinylthiocarbamyl relaxin for the demonstration of relaxin receptors.
    Segaloff A; Gabbard RB
    Ann N Y Acad Sci; 1982; 380():198-9. PubMed ID: 6282168
    [No Abstract]   [Full Text] [Related]  

  • 10. Activin and inhibin binding to the soluble extracellular domain of activin receptor II.
    Donaldson CJ; Vaughan JM; Corrigan AZ; Fischer WH; Vale WW
    Endocrinology; 1999 Apr; 140(4):1760-6. PubMed ID: 10098513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha 2-macroglobulin is a binding protein of inhibin and activin.
    Vaughan JM; Vale WW
    Endocrinology; 1993 May; 132(5):2038-50. PubMed ID: 7682939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for the presence of specific receptors for inhibin in human prostate.
    Phadke M; Vijayalakshmi S; Sheth AR
    Indian J Exp Biol; 1982 May; 20(5):419-20. PubMed ID: 6290382
    [No Abstract]   [Full Text] [Related]  

  • 13. Modulation of activin signal transduction by inhibin B and inhibin-binding protein (INhBP).
    Chapman SC; Woodruff TK
    Mol Endocrinol; 2001 Apr; 15(4):668-79. PubMed ID: 11266516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding characteristics of inhibin to rat pituitary plasma membrane.
    Vanage GR; Sheth AR
    Indian J Exp Biol; 1982 Jun; 20(6):45-7. PubMed ID: 6290383
    [No Abstract]   [Full Text] [Related]  

  • 15. In situ ligand binding of recombinant human [125I] activin-A and recombinant human [125I]inhibin-A to the adult rat ovary.
    Woodruff TK; Krummen L; McCray G; Mather JP
    Endocrinology; 1993 Dec; 133(6):2998-3006. PubMed ID: 8243328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transforming growth factor-beta modulates inhibin A bioactivity in the LbetaT2 gonadotrope cell line by competing for binding to betaglycan.
    Ethier JF; Farnworth PG; Findlay JK; Ooi GT
    Mol Endocrinol; 2002 Dec; 16(12):2754-63. PubMed ID: 12456797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Presence of specific receptor binding sites for inhibin in rat spermatids.
    Dandekar SP; Sheth AR; Ghosh D
    Andrologia; 1983; 15(3):274-8. PubMed ID: 6309035
    [No Abstract]   [Full Text] [Related]  

  • 18. Characterization of inhibin/activin subunit, follistatin, and activin type II receptors in human ovarian cancer cell lines: a potential role in autocrine growth regulation.
    Di Simone N; Crowley WF; Wang QF; Sluss PM; Schneyer AL
    Endocrinology; 1996 Feb; 137(2):486-94. PubMed ID: 8593793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of binding of human seminal alpha-inhibin-92 to human pituitary membranes.
    Ramasharma K; Li CH
    Proc Natl Acad Sci U S A; 1987 Jun; 84(11):3595-8. PubMed ID: 3035540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel activin receptors: distinct genes and alternative mRNA splicing generate a repertoire of serine/threonine kinase receptors.
    Attisano L; Wrana JL; Cheifetz S; Massagué J
    Cell; 1992 Jan; 68(1):97-108. PubMed ID: 1310075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.